SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-22-007493
Filing Date
2022-03-02
Accepted
2022-03-02 16:05:37
Documents
17
Period of Report
2022-03-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20002727x6_8k.htm   iXBRL 8-K 61505
2 EXHIBIT 4.1 ny20002727x6_ex4-1.htm EX-4.1 346590
3 EXHIBIT 5.1 ny20002727x6_ex5-1.htm EX-5.1 16962
8 ny20002727x6_ex5-1img01.jpg GRAPHIC 34794
9 ny20002727x6_ex5-1img02.jpg GRAPHIC 2374
  Complete submission text file 0001140361-22-007493.txt   732824

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bmy-20220302.xsd EX-101.SCH 4754
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bmy-20220302_def.xml EX-101.DEF 18396
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bmy-20220302_lab.xml EX-101.LAB 28485
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bmy-20220302_pre.xml EX-101.PRE 20689
11 EXTRACTED XBRL INSTANCE DOCUMENT ny20002727x6_8k_htm.xml XML 8440
Mailing Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016
Business Address 430 E. 29TH STREET 14 FLOOR NEW YORK NY 10016 2125464000
BRISTOL MYERS SQUIBB CO (Filer) CIK: 0000014272 (see all company filings)

IRS No.: 220790350 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-01136 | Film No.: 22703392
SIC: 2834 Pharmaceutical Preparations